Similar Articles
Encephalitis, Reversible Splenial Lesions, and COVID-19
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
DOI: 10.4274/tnd.2021.90093
Pandemic-Triggered Aberrant Drug Use may Cause Failure of Antiepileptic Therapy
Manolya Bergüzar Şekerlisoy, Aslıhan Taşkıran Sağ
DOI: 10.4274/tnd.2021.45804
Guillain-Barré Syndrome and COVID-19 Vaccines: A Comment
Joob Beuy, Viroj Wiwanitkit
DOI: 10.4274/tnd.2021.47048
Assesment of quality of life in neurological diseases
Sibel Karşıdağ, Yasemin Ekmekyapar Fırat, Fettah Eren, Sibel Canbaz Kabay, Murat Terzi
DOI: 10.4274/tnd.2023.56649
A rare variant of Guillain-Barré syndrome: Isolated bilateral facial paralysis
Saniye Karabudak, Zeliha Matur, Aslı Yaman Kula, Vildan Güzel, Ferda İlgen Uslu
DOI: 10.55697/tnd.2024.151
Characteristics of ischemic stroke during the COVID-19 pandemic
Mehmet Yalman, Fatma Münevver Gökyiğit, Zahide Mail Gürkan, Ridvan Yazgu
DOI: 10.55697/tnd.2025.253
Lessons learned and paths forward: Navigating the social landscape of multiple sclerosis care in the second wave of COVID-19
Nazire Pınar Acar Ozen, Dilara Cilizoglu, Bernanur Toprak, Nartan Demirok, Yeliz Salci, Rana Karabudak, Umut Beşpinar, Aslı Tuncer
DOI: 10.55697/tnd.2025.347
The impact of COVID-19 pandemic on adult individuals with neuromuscular disease
Muhammed Kılınç, Ender Ayvat, Özge Onursal Kılınç, Fatma Ayvat, Mert Doğan, Gülşah Sütçü Uçmak, Can Ebru Bekircan Kurt, Sevim Erdem Özdamar, Sibel Aksu Yıldırım, Ersin Tan
DOI: 10.55697/tnd.2025.358